Adagio Medical Holdings Azioni (NASDAQ: ADGM)

Ultime notizie per Adagio Medical Holdings (NASDAQ:ADGM) Azioni

Adagio Medical Holdings

Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for treatment of cardiac arrhythmias. The company focuses on developing innovative cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings Inc

Robert Mitchnick, head of digital assets at BlackRock, told a panel at the Benzinga <a href="https://www.benzinga.com/digital-assets">Future of Digital Assets </a>conference on Nov. 19 that options volume on the iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) breached the 1 billion <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42058823/blackrocks-spot-bitcoin-etf-to-open-for-options-trading-heres-why-it-could-be-a-big-deal-for-bitcoin">mark on Tuesday. </a>
"Things happen fast here," Mitchnick said. 
The Details: Nasdaq began listing options on BlackRock's spot Bitcoin ETF on Tuesday with 73,000 contracts traded in the first 90 minutes, ranking IBIT options among the top 20 most active non-index options. 
BlackRock's IBIT is currently the only spot Bitcoin ETF listed on Nasdaq, but competitors listed on the New York Stock Exchange (NYSE) and Cboe Global Markets are expected to launch similar options trading in the coming days.
Bloomberg senior ETF analyst Eric Balchunas noted that the volume was almost entirely calls, indicating a strong bullish sentiment in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>). 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A few hundred million so far in options volume on <a href="https://twitter.com/search?q=%24IBIT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$IBIT</a> (a ton for Day One).. here&#39;s a rank of the contracts by volume, it&#39;s almost all calls. Seems very bullish, esp the Dec20th C100, which is basically betting price of btc will double in the next month. <a href="https://t.co/R6HB7OMUla">pic.twitter.com/R6HB7OMUla</a>
&mdash; Eric Balchunas (@EricBalchunas) <a href="https://twitter.com/EricBalchunas/status/1858916477384225005?ref_src=twsrc%5Etfw">November 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42071163/blackrock-spot-bitcoin-etf-options-on-nasdaq-rack-up-9-figure-trading-volume-in-first-few-hours-seems-very-bullish-says-analyst">derivatives market </a>for traditional assets can often grow to be up to 20 times the size of the underlying asset&#8217;s market cap. If Bitcoin derivatives follow a similar trajectory, the listing of IBIT options could significantly expand the reach and functionality of Bitcoin-linked financial products.
"There's a ton of work to do to flesh out the investor opportunity and uptake around what we have," Mitchnick said. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a></li>
</ul>
Photo: John Dave from Pixabay

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Fintech news covering the emerging Financial Technology services sector

Fintech

News

Specialty ETFs

Options

Events

Movers

ETFs

$BTC

IBIT

BlackRock's Head Of Digital Assets Says IBIT Spot Bitcoin ETF Options Blow Past 1 Billion In Trading Volume

Congressman Matt Gaetz (R-Fla.) resigned from office after he was announced as President-elect Donald Trump's pick<a href="https://www.benzinga.com/news/legal/24/11/41956594/matt-gaetz-is-trumps-attorney-general-pick-would-be-top-cop-is-under-house-ethics-investigation"> for attorney general.</a>
While Gaetz has not been formally nominated for the White House role, his resignation could keep an investigation into his actions from being publicly released.
What Happened: Prior to<a href="https://www.benzinga.com/news/24/11/42024613/lawyer-ethics-committee-witness-says-she-saw-ag-nominee-gaetz-having-sex-with-a-minor"> resigning from Congress</a>, Gaetz was under investigation by the House Ethics Committee for allegations of sexual misconduct, drug use and more.
With Gaetz no longer a member of Congress, the Ethics Committee has no jurisdiction over him, but their decision of whether to release their findings publicly remains one of the biggest topics for Congress this week.
The Ethics Committee, which is evenly split between Democrats and Republicans, is expected to meet Wednesday to determine their next step in whether to release the report or not, the Wall Street Journal <a href="https://www.wsj.com/politics/policy/senators-want-details-on-sexual-misconduct-allegations-as-gaetz-seeks-fair-shake-7a1bfad7?mod=hp_lead_pos1">reported</a>.
The report would likely include the committee's findings into allegations that Gaetz had sexual relations with a 17-year-old minor. The former minor and another woman both said Gaetz paid them for sex, according to comments from their lawyer on Monday.
Gaetz denied allegations of having sex with a minor, sex trafficking or paying for sex previously.
Speaker of the House Mike Johnson (R-La.) said this week it would be a bad precedent if the committee releases the report with Gaetz no longer a member of Congress.
See Also: <a href="https://www.benzinga.com/politics/24/11/42077496/donald-trumps-personnel-picks-new-poll-finds-elon-musk-with-highest-approval-by-voters-matt-gaetz-with-highest-disapproval">Donald Trump&#8217;s Personnel Picks: New Poll Finds Elon Musk With Highest Approval By Voters, Matt Gaetz With Highest Disapproval</a>
Some members of Congress, including members of the Republican party, want to see the results of the committee ahead of a potential vote for Gaetz to be a member of Trump's cabinet.
"I'm saying to the people that want any cabinet person to get through — not just Gaetz — but it's going to be a lot faster if you give us all the information that we want," Sen. Chuck Grassley (R-Iowa) said.
The Ethics Committee previously planned to release their findings last week before Gaetz surprising resignation.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent111924">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Why It's Important: While The Republicans will have a majority of 53-47 when the new Congress term begins in January, four Republicans voting against any pick could see them fail to be approved through, assuming all Democrats vote against the candidate.
On Tuesday it was reported that an "unknown and unauthorized third party" gained access to depositions from witnesses in the Gaetz investigation, as <a href="https://www.cbsnews.com/news/matt-gaetz-depositions-leak-investigations/">reported </a>by CBS News.
The reported leak, which could include testimony from the minor who allegedly had sex with Gaetz, could put into question whether more details from the case will be released publicly, even if Congress doesn't do so.
On <a href="https://polymarket.com/event/who-will-be-trumps-attorney-general?tid=1732054162608">Polymarket</a>, the odds of Gaetz being approved as attorney general currently stand at 38%, up from <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42014985/matt-gaetz-to-be-confirmed-as-attorney-general-in-a-trump-administration-not-so-fast-polymarket-traders-say">28% four days ago. </a>The odds had previously hovered between 25% and 30%, before growing in recent days.
Gaetz has the best odds of any name listed in the Polymarket attorney general prediction market. On Polymarket, users can deposit funds using USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) via the Polygon (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/matic/usd">MATIC</a>) network, or directly from a crypto account with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>).
Each betting market sees the winning option pay out at $1. Like the 2024 election markets, the odds of potential cabinet members are becoming hot betting markets on Polymarket.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/42036132/trump-wants-matt-gaetz-confirmed-100-so-does-the-cannabis-industry">Trump Wants Matt Gaetz Confirmed &#8216;100%,&#8217; So Does The Cannabis Industry</a></li>
</ul>
Photo: Shutterstock

Government

Politics

Legal

$ETH

$MATIC

$USDC

USDC

Trump's Attorney General Pick Matt Gaetz Resigned From Congress, Ethics Committee To Decide If Report Will Be Released

President-elect Donald J. Trump <a href="https://www.benzinga.com/general/health-care/24/11/42077057/trump-picks-dr-oz-as-centers-for-medicare-and-medicaid-services-administrator">announced on Tuesday afternoon</a> that he will nominate TV personality Dr. Mehmet Oz to serve as the administrator of the Centers for <a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks" target="_blank" rel="noreferrer noopener">Medicare and Medicaid Services (CMS)</a>. The appointment is among a string of TV hosts — mostly from Fox News — to be chosen to join Trump's cabinet.
In a statement, Trump said the celebrity TV host will "work closely with Robert F. Kennedy Jr. to take on the illness industrial complex."
Though a household name due to his long-running &#8220;The Dr. Oz Show" (2009-2022), Oz got into politics when he <a href="https://www.benzinga.com/markets/cannabis/22/06/27558526/dr-oz-to-face-john-fetterman-in-unprecedented-unpredictable-pa-senate-race-and-cannabis-is-on-th">unsuccessfully ran for Senate</a> against now Sen. John Fetterman (D-Penn.) in 2022, during which time the good doctor seemed to forge an alliance with Trump.
At the time, Scientific American&nbsp;<a href="https://www.scientificamerican.com/article/dr-oz-shouldnt-be-a-senator-or-a-doctor/" target="_blank" rel="noreferrer noopener">wrote </a>Dr. Oz should not&nbsp;be a senator or a doctor, noting that his misinformation had already tarnished medicine and would do much worse in the halls of Congress.&nbsp;"Dr. Oz&nbsp;has long pushed misleading, science-free and unproven alternative therapies such as homeopathy, as well as fad diets, detoxes and cleanses."
<h1 class="wp-block-heading">Donald Trump Begs To Differ</h1>
News outlets are quick to<a href="https://www.axios.com/2024/11/19/trump-dr-oz-cms-cabinet"> point out</a> that Dr. Oz has no experience running a large government body like the CMS but that seems to not matter because, according to the President-elect.
&#8220;There may be no Physician more qualified and capable than Dr. Oz to Make America Healthy Again,&#8221; Trump said in a statement, referring to the words of <a href="https://www.benzinga.com/topic/robert-f-kennedy-jr">Robert Kennedy Jr</a>. who will, if confirmed run the Dept. of Health and Human Services.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/11/42036132/trump-wants-matt-gaetz-confirmed-100-so-does-the-cannabis-industry">Trump Wants Matt Gaetz Confirmed &#8216;100%,&#8217; So Does The Cannabis Industry</a>
<h1 class="wp-block-heading">Dr. Oz On Cannabis</h1>
The multimillionaire TV host initially called cannabis a &#8220;mixed bag for easing pain.&#8221; But a recent discussion with&nbsp;Michael Roizen,&nbsp;M.D., of the Wellness Institute at the Cleveland Clinic, Dr. <a href="https://www.benzinga.com/markets/cannabis/24/08/40492959/trump-endorsed-dr-oz-on-medical-marijuana-and-pain-give-it-a-try">Oz said</a>, &#8220;Our advice: If your physician recommends it to manage pain, especially if you&#8217;re 65 and older, give it a try.&#8221;
While Dr. Oz cautions against cannabis consumption for recreational purposes, he said he believes marijuana for pain represents a "safer solution than, for example, narcotics in many cases."
During his Senate race, Dr. Oz often criticized Fetterman&#8217;s support for cannabis legalization though several years earlier he himself <a href="https://www.marijuanamoment.net/dr-oz-claims-dea-and-fda-blame-each-other-for-keeping-marijuana-illegal/">referred to cannabis</a>&nbsp;as "one of the most underused tools in America" and that the U.S. should&nbsp;"completely change our policy on marijuana."
Now Read:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/42069004/how-trumps-election-could-revolutionize-cannabis-and-cryptocurrency-ceo-says">How Trump&#8217;s Election Could Revolutionize Cannabis And Cryptocurrency, CEO Says</a></li>
</ul>

Cannabis

Health Care

Trump Picks Dr. Oz, Who Says Seniors Should Give Medical Marijuana A Try, To Lead Centers For Medicare And Medicaid Services

AZEK Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) sees FY2025 sales of $1.510 billion-1.540 billion vs $1.43 billion estimate.

Guidance

AZEK

AZEK Co Sees FY2025 Sales $1.510B-1.540B vs $1.43B Est

Kore Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KORE#NYSE">KORE</a>) raises FY2024 sales outlook from $275.00 million-285.00 million to $280.00 million-285.00 million.

KORE

Kore Group Holdings Raises FY2024 Sales Guidance from $275.00M-285.00M to $280.00M-285.00M

Varex Imaging (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VREX#NASDAQ">VREX</a>) is looking for Q1 Adj EPS of $(0.05)-0.10 vs $0.04 analyst estimate. sees sales of $195.000 million-215.000 million vs $189.43 million estimate.

VREX

Varex Imaging Sees Q1 Adj EPS $(0.05)-0.10 vs $0.04 Est; Sees Sales $195.000M-215.000M vs $189.43M Est

Keysight Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEYS#NYSE">KEYS</a>) is looking for Q1 Adj EPS of $1.65-1.71 vs $1.57 analyst estimate. sees sales of $1.265 billion-1.285 billion vs $1.26 billion estimate.

KEYS

Keysight Techs Sees Q1 Adj EPS $1.65-1.71 vs $1.57 Est; Sees Sales $1.265B-1.285B vs $1.26B Est

Concentra Group To Replace Myers Industries In S&P SmallCap 600 Effective Prior To Opening Of Trading On November 27

AZTA

Azenta To Replace Envestnet In S&P SmallCap 600 Effective Prior To The Opening Of Trading On November 25

FLEX

Flex To Replace Azenta In S&P MidCap 400

Donald Trump has announced several picks for potential nominees for his White House administration since winning the <a href="https://www.benzinga.com/news/24/11/41768178/donald-trump-defeats-kamala-harris-to-win-2024-election">2024 presidential election.</a>
While the picks still have to be nominated and approved in many cases, voters were recently asked to share whether they approve of or disapprove of his current selections.
What Happened: Trump's announced picks have generated plenty of discussion on social media and across the political spectrum with the announced picks of Matt Gaetz <a href="https://www.benzinga.com/news/legal/24/11/41956594/matt-gaetz-is-trumps-attorney-general-pick-would-be-top-cop-is-under-house-ethics-investigation">as attorney general</a> and Robert F. Kennedy Jr. leading the Health and Human Services generating the most buzz.
A new Morning Consult <a href="https://pro.morningconsult.com/analysis/trump-transition-nominees-approval">poll </a>asked voters how they think Trump is doing with his transition.
The poll found that 54% of voters approve of Trump's handling of his transition since winning the 2024 election, with 38% disapproving and 8% saying they don't know or had no opinion.
Split by political party, Republicans showed a higher approval rating (93%) of Trump's handling of the transition compared to Democrats (20%). Independent voters were more split with 46% approving, 40% disapproving and 14% having no opinion or saying they don't know.
Trump's 54% approval rating is only six points below the 60% approval rating President Joe Biden had four years ago from a Morning Consult poll.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent111924">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Personnel Pick Ratings: Here are the approval and disapproval ratings of recent personnel picks by Trump for his next White House term.
<ul>
<li>Mike Huckabee, U.S. Ambassador to Israel: 44% approval, 31% disapproval, 25% no opinion</li>
<li>Marco Rubio, Secretary of State: 45% approval, 34% disapproval, 21% no opinion</li>
<li>Elise Stefanik, U.S. Ambassador to the United Nations: 38% approval, 29% disapproval, 33% no opinion</li>
<li>Stephen Miller, Deputy White House Chief of Staff: 36% approval, 30% disapproval, 34% no opinion</li>
<li>Tulsi Gabbard, Director of National Intelligence: 39% approval, 33% disapproval, 29% no opinion</li>
<li>Robert F. Kennedy Jr., Health and Human Services Secretary: 44% approval, 39% disapproval, 16% no opinion</li>
<li>Elon Musk, co-leader of the Department of Government Efficiency: 45% approval, 40% disapproval, 15% no opinion</li>
<li>Vivek Ramaswamy, co-leader of the Department of Government Efficiency: 39% approval, 34% disapproval, 27% no opinion</li>
<li>Lee Zeldin, Environmental Protection Agency Administration: 34% approval, 29% disapproval, 37% no opinion</li>
<li>Pete Hegseth, Secretary of Defense: 37% approval, 32% disapproval, 31% no opinion</li>
<li>Kristi Noem, Secretary of Homeland Security: 37% approval, 33% disapproval, 30% no opinion</li>
<li>Matt Gaetz, Attorney General: 34% approval, 41% disapproval, 25% no opinion</li>
</ul>
Why It's Important: The selection of Gaetz could face the most scrutiny by members of Congress if he is formally nominated. The Republican resigned from Congress the same day Trump announced the attorney general role for him.
Gaetz was investigated by the Department of Justice for sex trafficking before it declined to charge the congressman.
The former Congressman was under investigation by the House Ethics Committee for sexual misconduct. Allegations against the Trump ally include sexual misconduct, illicit drug use, accepting improper gifts and more. Gaetz has denied the allegations.
Gaetz is the only person in the poll to receive a higher percentage of disapproval than approval.
When it comes to disapproval, Gaetz ranks first at 41% followed by Tesla CEO Elon Musk at 40%.
Musk, who has been named by Trump to lead the Department of Government Efficiency and cut government spending, also has the <a href="https://www.benzinga.com/politics/24/11/41993300/elon-musks-favorability-with-gop-voters-nearly-as-high-as-j-d-vance-how-views-of-billionaire-changed-among-political-parties">highest approval rating</a> at 45%, tied with Marco Rubio.
Musk has the lowest percent of voters saying no opinion, showing how opinionated voters are of his potential selection. Musk maintains a positive net approval rating of 45% to a disapproval rating of 40%.
Kennedy Jr. ranks among the highest for approval at 44% and for disapproval at 39%. Like Musk, Kennedy also has a low amount of voters saying they have no opinion at 16%.
Huckabee has the highest net approval rating in the poll at 13 points.
This poll was taken before Trump announced Dr. Mehmet Oz as his choice as <a href="https://www.benzinga.com/general/health-care/24/11/42077057/trump-picks-dr-oz-as-centers-for-medicare-and-medicaid-services-administrator">Centers For Medicare and Medicaid Services administrator</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/11/42036132/trump-wants-matt-gaetz-confirmed-100-so-does-the-cannabis-industry">Trump Wants Matt Gaetz Confirmed &#8216;100%,&#8217; So Does The Cannabis Industry</a></li>
</ul>
Photo: Musk, White House, public domain; Trump and Getz, Shutterstock

Donald Trump's Personnel Picks: New Poll Finds Elon Musk With Highest Approval By Voters, Matt Gaetz With Highest Disapproval

Telsey Advisory Group analyst Joseph Feldman maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Outperform and raises the price target from $92 to $100.

Price Target

Analyst Ratings

Telsey Advisory Group Maintains Outperform on Walmart, Raises Price Target to $100

ZTO Cuts 2024 Outlook For Parcel Volume From 34.73B - 35.64B To 33.7B - 33.9B Based On Current Market And Operating Conditions

KITT

Nauticus Robotics Enters Strategic Collaboration With SeaTrepid To Integrate And Test Its ToolKITT Software On Remotely Operated Vehicles

Canaccord Genuity analyst Caitlin Cronin maintains Vericel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCEL#NASDAQ">VCEL</a>) with a Buy and maintains $60 price target.

VCEL

Canaccord Genuity Maintains Buy on Vericel, Maintains $60 Price Target

Canaccord Genuity analyst Whitney Ijem maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and maintains $80 price target.

RYTM

Canaccord Genuity Maintains Buy on Rhythm Pharmaceuticals, Maintains $80 Price Target

Earnings

LDWY

Lendway Q3 EPS From Continuing Operations $(0.67) Up From $(0.85) YoY, Sales $6.6M

Canaccord Genuity analyst Whitney Ijem maintains Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) with a Buy and maintains $39 price target.

RCKT

Canaccord Genuity Maintains Buy on Rocket Pharmaceuticals, Maintains $39 Price Target

The Company intends to use the net proceeds from this offering, together with proceeds from the expected issuance of up to $650 million aggregate principal amount of new senior secured notes, borrowings under our revolving credit facility and cash on hand, to fund the consideration payable by us in the previously-announced, pending acquisition of all of the equity interests in Guardian Pipeline, L.L.C., Midwestern Gas Transmission Company and Viking Gas Transmission Company from ONEOK Partners Intermediate Limited Partnership and Border Midwestern Company.

Offerings

ZTO DT Midstream Commences Public Offering Of $300M Of Shares Of Common Stock

Canaccord Genuity analyst Whitney Ijem maintains Intellia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) with a Buy and maintains $90 price target.

NTLA

Canaccord Genuity Maintains Buy on Intellia Therapeutics, Maintains $90 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start off the final trading day of the week with a breakdown of the biggest pre-market stock movers for Friday morning!



Moving stocks this morning are earnings reports, a failed merger deal, delisting updates and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>VSee Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/vsee-stock-quote/">VSEE</a>) stock is rocketing more than 159% as the robot maker <a href="https://www.nasdaq.com/press-release/vsee-health-and-ava-robotics-partner-develop-telepresence-solutions-hospital">plans for telepresence solutions</a> for the inpatient intensive care market.</li>



<li>Adagio Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/adgm-stock-quote/">ADGM</a>) shares are soaring close to 36% following its <a href="https://www.businesswire.com/news/home/20240731222906/en/Adagio-Medical-Announces-the-Closing-of-the-Business-Combination-with-ARYA-IV-Creating-a-Publicly-Traded-Company-Focused-on-the-Innovative-Technologies-for-Treatment-of-Cardiac-Arrhythmias">recent public debut</a>.</li>



<li>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) stock is surging over 35% alongside heavy pre-market trading.</li>



<li>Exicure (NASDAQ:<a href="https://investorplace.com/stock-quotes/xcur-stock-quote/">XCUR</a>) shares are gaining more than 29% on a <a href="https://www.businesswire.com/news/home/20240801299565/en/Exicure-Inc.-Receives-Positive-Listing-Determination-from-Nasdaq">positive listing update</a> from the Nasdaq Capital Market.</li>



<li>Australian Oilseeds (NASDAQ:<a href="https://investorplace.com/stock-quotes/coot-stock-quote/">COOT</a>) stock is rising 25% after announcing a <a href="https://www.nasdaq.com/press-release/australian-oilseeds-announces-appointment-new-independent-auditor-2024-08-01">new independent auditor</a>.</li>



<li>Tandem Diabetes Care (NASDAQ:<a href="https://investorplace.com/stock-quotes/tndm-stock-quote/">TNDM</a>) shares are increasing nearly 25% with the release of its <a href="https://www.nasdaq.com/press-release/tandem-diabetes-care-announces-second-quarter-2024-financial-results-and-increases">Q2 earnings report</a>.</li>



<li>Vaccinex (NASDAQ:<a href="https://investorplace.com/stock-quotes/vcnx-stock-quote/">VCNX</a>) stock is heading over 23% higher with <a href="https://www.nasdaq.com/press-release/vaccinex-reports-positive-data-signal-ad-phase-1b-2-trial-pepinemab-alzheimers">recent clinical trial news</a>.</li>



<li>AGBA Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/agba-stock-quote/">AGBA</a>) shares are climbing more than 13% without any clear news this morning.</li>



<li>Venus Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/vero-stock-quote/">VERO</a>) stock is jumping over 13% on Friday morning.</li>



<li>Integral Ad Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/ias-stock-quote/">IAS</a>) shares are up 13% with its <a href="https://www.nasdaq.com/press-release/ias-reports-second-quarter-2024-financial-results-2024-08-01">latest earnings news</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Gamer Pakistan (NASDAQ:<a href="https://investorplace.com/stock-quotes/gpak-stock-quote/">GPAK</a>) stock is plummeting almost 47% <a href="https://www.pr.com/press-release/917157#:~:text=(Nasdaq%3AGPAK)%20(GPAK,and%20that%20trading%20of%20the">alongside a delisting notice</a>.</li>



<li>Fresh Vine Wine (NYSEMKT:<a href="https://investorplace.com/stock-quotes/vine-stock-quote/">VINE</a>) shares are diving more than 37% with the <a href="https://www.nasdaq.com/press-release/fresh-vine-wine-inc-and-notes-live-inc-mutually-agree-terminate-merger-agreement-2024">termination of a merger agreement</a>.</li>



<li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) stock is tumbling over 30% as Badcock Home Furniture &amp; More <a href="https://nypost.com/2024/08/01/business/major-furniture-chain-badcock-to-shut-all-its-stores-after-120-years/">shuts down all of its stores</a>.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are taking a more than 24% beating on plans for a <a href="https://www.stocktitan.net/news/GNLN/greenlane-announces-board-s-approval-of-reverse-stock-split-9yehmvs5r4ed.html">reverse stock split</a>.</li>



<li>Procore Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/pcor-stock-quote/">PCOR</a>) stock is dropping 22% alongside its <a href="https://www.nasdaq.com/press-release/procore-announces-second-quarter-2024-financial-results-2024-08-01">Q2 earnings report</a>.</li>



<li>Estrella Immunopharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/esla-stock-quote/">ESLA</a>) shares are sliding close to 21% on Friday morning.</li>



<li>Intel (NASDAQ:<a href="https://investorplace.com/stock-quotes/intc-stock-quote/">INTC</a>) stock is falling over 20% after releasing its <a href="https://www.theverge.com/2024/8/1/24210656/intel-is-laying-off-over-10000-employees-and-will-cut-10-billion-in-costs">Q2 earnings report</a>.</li>



<li>Smith Micro Software (NASDAQ:<a href="https://investorplace.com/stock-quotes/smsi-stock-quote/">SMSI</a>) shares are decreasing more than 19% with its <a href="https://seekingalpha.com/article/4709513-smith-micro-software-inc-smsi-q2-2024-earnings-call-transcript">latest earnings report</a>.</li>



<li>GraniteShares 2x Long AMZN Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/amzz-stock-quote/">AMZZ</a>) stock is slipping over 17%.</li>



<li>Snap (NYSE:<a href="https://investorplace.com/stock-quotes/snap-stock-quote/">SNAP</a>) shares close out our pre-market stock movers down more than 17% <a href="https://www.cnbc.com/2024/08/01/snap-shares-plunge-over-20percent-af.html">on weak guidance</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-aug-2nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Tuesday as we check out all of the hottest news moving shares this morning.



Moving stocks are several new deals, delisting notices and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Vicinity Motor (NASDAQ:<a href="https://investorplace.com/stock-quotes/vev-stock-quote/">VEV</a>) stock is rocketing more than 153% alongside heavy pre-market trading.</li>



<li>CXApp (NASDAQ:<a href="https://investorplace.com/stock-quotes/cxai-stock-quote/">CXAI</a>) shares are soaring over 61% after <a href="https://www.nasdaq.com/press-release/cxapp-inc-nasdaq-cxai-announces-largest-expansion-deal-strategic-multi-year-0">signing an expansion deal</a> with Google Cloud.</li>



<li>MKDWell Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/mkdw-stock-quote/">MKDW</a>) stock is surging more than 57% alongside <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318514393&amp;type=PDF&amp;symbol=MKDW&amp;cdn=59d6d4925634abb97d78eb6b63a094fb&amp;companyName=MKDWELL+Tech+Inc.&amp;formType=SC+13D&amp;formDescription=General+statement+of+acquisition+of+beneficial+ownership&amp;dateFiled=2024-08-12">new investment news</a>.</li>



<li>Pono Capital Two (NASDAQ:<a href="https://investorplace.com/stock-quotes/ptwo-stock-quote/">PTWO</a>) shares are rising over 37% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318512443&amp;type=PDF&amp;symbol=PTWO&amp;cdn=c007f907da889b37797c3a70ef100ef9&amp;companyName=Pono+Capital+Two+Inc.&amp;formType=DEFM14A&amp;formDescription=Definitive+proxy+statement+relating+to+merger+or+acquisition&amp;dateFiled=2024-08-12">proposed merger plan</a>.</li>



<li>Psychemedics (NASDAQ:<a href="https://investorplace.com/stock-quotes/pmd-stock-quote/">PMD</a>) stock is increasing more than 20% on <a href="https://www.nasdaq.com/press-release/psychemedics-corporations-board-directors-approves-plan-terminate-registration-its">plans to delist its shares</a>.</li>



<li>Hesai (NASDAQ:<a href="https://investorplace.com/stock-quotes/hsai-stock-quote/">HSAI</a>) shares are climbing over 19% without any clear news.</li>



<li>Roadzen (NASDAQ:<a href="https://investorplace.com/stock-quotes/rdzn-stock-quote/">RDZN</a>) stock is heading more than 18% higher despite a lack of news today.</li>



<li>QT Imaging (NASDAQ:<a href="https://investorplace.com/stock-quotes/qti-stock-quote/">QTI</a>) shares are getting an over 17% boost on Tuesday morning.</li>



<li>Adagio Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/adgm-stock-quote/">ADGM</a>) stock is jumping more than 17% without any recent news.</li>



<li>GCT Semiconductor (NYSE:<a href="https://investorplace.com/stock-quotes/gcts-stock-quote/">GCTS</a>) shares are up over 17% after <a href="https://www.nasdaq.com/press-release/gct-semiconductor-signs-mou-samsung-accelerate-development-4g-5g-chipsets-and-modules">signing an agreement</a> with Samsung.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Syros Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/syrs-stock-quote/">SYRS</a>) stock is crashing more than 58% on a <a href="https://www.nasdaq.com/press-release/syros-provides-update-select-aml-1-phase-2-clinical-trial-2024-08-12">Phase 2 clinical trial update</a>.</li>



<li>PS International (NASDAQ:<a href="https://investorplace.com/stock-quotes/psig-stock-quote/">PSIG</a>) shares are diving over 21% <a href="https://investorplace.com/2024/08/why-is-ps-international-psig-stock-up-64-today/">after a massive rally yesterday</a>.</li>



<li>SunPower (NASDAQ:<a href="https://investorplace.com/stock-quotes/spwr-stock-quote/">SPWR</a>) stock is tumbling more than 19% on a <a href="https://finance.yahoo.com/news/sunpower-announces-nasdaq-delisting-notification-205800088.html">Nasdaq delisting notification</a>.</li>



<li>Greenlane (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnln-stock-quote/">GNLN</a>) shares are taking an over 18% beating after rallying yesterday <a href="https://investorplace.com/2024/08/why-is-greenlane-gnln-stock-up-210-today/">on Safety Strips news</a>.</li>



<li>Surf Air Mobility (NYSE:<a href="https://investorplace.com/stock-quotes/srfm-stock-quote/">SRFM</a>) stock is sliding more than 18% after announcing an <a href="https://www.tipranks.com/news/company-announcements/surf-air-mobility-announces-optimistic-ai-joint-venture">artificial intelligence (AI) joint venture</a>.</li>



<li>HNR Acquisition (NYSEMKT:<a href="https://investorplace.com/stock-quotes/hnra-stock-quote/">HNRA</a>) shares are decreasing close to 16% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318511957&amp;type=PDF&amp;symbol=HNRA&amp;cdn=eb4e7e579bfe6b9a9328f0eca81fc1b2&amp;companyName=HNR+Acquisition+Corp+Class+A&amp;formType=424B3&amp;formDescription=Prospectus+%5BRule+424%28b%29%283%29%5D&amp;dateFiled=2024-08-12">proposed secondary offering</a>.</li>



<li>FSD Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/huge-stock-quote/">HUGE</a>) stock is retreating over 15% <a href="https://investorplace.com/2024/08/fsd-pharma-is-up-216-today-what-is-going-on-with-huge-stock/">after a Monday rally</a>.</li>



<li>Interactive Strength (NASDAQ:<a href="https://investorplace.com/stock-quotes/trnr-stock-quote/">TRNR</a>) shares are dropping more than 15% <a href="https://investorplace.com/2024/08/why-is-interactive-strength-trnr-stock-up-59-today/">following a rally yesterday</a>.</li>



<li>Yatra Online (NASDAQ:<a href="https://investorplace.com/stock-quotes/ytra-stock-quote/">YTRA</a>) stock is falling over 14% on a <a href="https://www.tipranks.com/news/company-announcements/yatra-online-reports-mixed-quarterly-performance">mixed earnings report</a>.</li>



<li>Conifer (NASDAQ:<a href="https://investorplace.com/stock-quotes/cnfr-stock-quote/">CNFR</a>) shares are down more than 12% ahead of an <a href="https://www.nasdaq.com/press-release/conifer-holdings-schedules-second-quarter-2024-earnings-conference-call-webcast">earnings conference call tomorrow</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-aug-13th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Adagio Medical (ADGM) Holdings announced the completion of the first procedures in FULCRUM-VT U.S. Food and Drug Administration FDA Pivotal IDE stu...

Adagio completes first procedures in FULCRUM-VT IDE of VT cryoablation system

Adagio Medical reports Q3 results

ADGM

AGBA

AKAN

AMZZ

CNFR

CONN

COOT

CXAI

ESLA

GCTS

GNLN

GPAK

HNRA

HSAI

HUGE

INTC

MKDW

PCOR

PSIG

PTWO

RDZN

SMSI

SNAP

SPWR

SRFM

SYRS

TNDM

TRNR

VCNX

VERO

VINE

VSEE

XCUR

YTRA

Press Releases

Adagio Medical Provides Business Updates

Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias

Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System

Comments

Adagio Medical Holdings

Notizie

Ultime notizie per Adagio Medical Holdings (NASDAQ:ADGM) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO